Allogeneic Hematopoietic Stem Cell Transplant Recipients and Skin Cancer Risk: A Commercial Claims Cohort Study

J Invest Dermatol. 2025 Jan 9:S0022-202X(25)00002-8. doi: 10.1016/j.jid.2024.10.617. Online ahead of print.

Authors

Cassandra Mohr¹, Yao Li², Lucy J Navsaria², Candice L Hinkston², Mackenzie R Wehner³

Affiliations

¹ McGovern Medical School, Houston, Texas, USA.
² Department of Health Services Research, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
³ Department of Health Services Research, University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Dermatology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Electronic address: mwehner@mdanderson.org.

PMID: 39798785
DOI: 10.1016/j.jid.2024.10.617

No abstract available

Keywords: Epidemiology; Health services research; Hematopoiesis; Public health research; Stem cells.